课题基金 / 基金详情

SMAD MEDIATED SIGNALING DURING LUNG MORPHOGENESIS

SMAD MEDIATED SIGNALING DURING LUNG MORPHOGENESIS
肺形态发生过程中 SMAD 介导的信号传导
批准号:
6390086
负责人:
WEI SHI
金额:
$25.05万
依托单位国家:
美国
项目类别:
财政年份:
1999
资助国家:
美国
项目状态:
已结题
起止时间:
1999-08-01 至 2003-07-31

项目摘要

项目成果

WEI SHI的其他基金

相似基金

相关文献

中文摘要
翻译
肺分子胚胎学的研究可能为肺发育、损伤和疾病的分子机制提供重要的新认识。我们已经证明tgf - β受体介导的自分泌/旁分泌信号负调控早期肺发育。最近对Smad家族信号传导蛋白的鉴定揭示了tgf - β信号从细胞膜到细胞核的新机制,我们的初步数据表明Smad介导的信号传导调节小鼠肺分支的形态发生和细胞分化。假设:Smad基因特异性表达调控tgf - β信号,从而指导小鼠早期胚胎肺分支形态发生。具体目标:目标1。定义Smad基因在胚胎肺发育(i)体内和(ii)肺外植体培养过程中的发育和时空表达。目标2。利用(i)“功能丧失”和(ii)“功能获得”策略,确定tgf - β通路限制性Smad2和Smad3调节无血清培养中胚胎肺分支形态发生和细胞分化的分子机制。目标3。明确反馈抑制Smad6和Smad7蛋白在培养胚胎肺分支形态发生中的生物学功能。(i)时间和剂量依赖性tgf - β诱导的抑制Smad6和Smad7基因表达模式将在肺外植体培养中描述。(ii)抑制Smad6和Smad7对肺发育过程中tgf - β信号的拮抗机制将在胚胎肺培养中确定。控制肺形态发生的新分子机制及其对人类健康的意义:目前的提案将定义smad介导的信号调节胚胎肺分支形态发生的新分子机制。该项目的结果将为在肺发育、损伤、修复和疾病过程中调节tgf - β信号的新治疗策略提供新的理论依据。
英文摘要
Studies of the molecular embryology of the lung are likely to provide significant new understanding of the molecular mechanisms of lung development, injury and disease. We have demonstrated that TGF-beta receptor-mediated autocrine/paracrine signaling negatively regulates early lung development. The recent identification of the Smad family signal transducer proteins has unraveled new mechanisms by which TGF-beta signals from the cell membrane to the nucleus, and our preliminary data show that Smad-mediated signaling modulates mouse lung branching morphogenesis and cytodifferentiation. Hypothesis: Specific Smad gene expression regulates TGF-beta signaling, and thus instructs early mouse embryonic lung branching morphogenesis. Specific Aims: Aim 1. To define the developmental and temporo-spatial expression of Smad genes during embryonic lung development (i) in vivo and (ii) in lung explant culture. Aim 2. To determine the molecular mechanism of TGF-beta pathway- restricted Smad2 and Smad3 in regulating embryonic pulmonary branching morphogenesis and cytodifferentiation in serumless culture using both (i) "loss-of-function" and (ii) "gain-of- function" strategies. Aim 3. To define the biological function of the feedback inhibitory Smad6 and Smad7 proteins during embryonic lung branching morphogenesis in culture. (i) Time- and dose-dependent TGF-beta-induced inhibitory Smad6 and Smad7 gene expression patterns will be delineated in lung explant culture. (ii) The antagonistic mechanism by inhibitory Smad6 and Smad7 on TGF-beta signaling during lung development will be determined in embryonic lung culture. Novel molecular mechanisms to control lung morphogenesis and significance to human health: The current proposal will define novel molecular mechanisms in which Smad-mediated signaling regulates embryonic lung branching morphogenesis. The results of this project will provide new rationales for novel therapeutic strategies to modulate TGF-beta signaling during lung development, injury, repair, and disease.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Pathogenic Mechanisms of Pulmonary Lymphangioleiomyomatosis
  • 批准号:
    10768216
  • 项目类别:
  • 资助金额:
    $30.61万
  • 财政年份:
    2023
  • 负责人:
    WEI SHI
  • 依托单位:
Lung Development and Diseases
Lung Development and Diseases
  • 批准号:
    10573209
  • 项目类别:
  • 资助金额:
    $49.55万
  • 财政年份:
    2022
  • 负责人:
    WEI SHI
  • 依托单位:
Molecular mechanisms of pulmonary disease in Birt-Hogg-Dube syndrome
  • 批准号:
    10805544
  • 项目类别:
  • 资助金额:
    $12.75万
  • 财政年份:
    2018
  • 负责人:
    WEI SHI
  • 依托单位:
海外基金